What projects are we looking for?

The aim of Actar is to develop drugs against targets* in collaboration with academic researchers.

Actar is interested in projects where the purpose is to identify small molecules active against a novel target or a known target with a novel approach to identify an active compound.

Ideally, the target should be validated (proven essential in a disease process) and no other competing company should work on the same target.

* Target: molecule in the human body that play an important role in disease progression.